Meeting Details

The 31st Annual General Meeting of Kobo Biotech Limited was held on Friday, July 24, 2026, commencing at 10:00 AM and concluding at 10:09 AM. The meeting was conducted entirely through Video Conferencing / Other Audio Visual Means (VC/OAVM) facility.

Shareholder Participation and Attendance

  • Total number of shareholders on the record date: 7,903
  • Number of shareholders present in the meeting: 35 (all through video conference)
  • No shareholders attended in person or through proxy
  • Promoter and Promoter Group participation: 0 shareholders, representing 0 shares (0% of share capital)
  • Public shareholder participation: 35 shareholders, representing 13,668 shares (0.0574% of total share capital)
  • Total shares represented at meeting: 13,668 shares (0.0574% of total capital)

Voting Process and Scrutinizer Appointment

The company provided remote e-voting facilities to members pursuant to Regulation 44 of SEBI LODR Regulations and Section 108 of the Companies Act, 2013.

  • Remote e-voting period: July 21, 2026 (9:00 AM IST) to July 23, 2026 (5:00 PM IST)
  • Scrutinizer appointed: Mrs. Riddhi Shah, Practising Company Secretary
  • Ms. Riddhi Shah was also appointed to scrutinize the venue voting process, though no venue voting occurred

Resolution Considered and Voting Results

The AGM considered one ordinary resolution:

1. Adoption of Annual Accounts and Reports for the financial year ended March 31, 2024

Voting Results Breakdown:

Promoter and Promoter Group Voting:

  • Shares held: 10,709,100
  • Votes polled: 0 (0% of shares held)
  • Votes in favor: 0
  • Votes against: 0

Public Institutions Voting:

  • Shares held: 100
  • Votes polled: 0 (0% of shares held)
  • Votes in favor: 0
  • Votes against: 0

Public Non-Institutions Voting:

  • Shares held: 13,115,800
  • Votes polled: 17,934 (0.1367% of shares held)
  • Votes in favor: 17,934 (100% of votes polled)
  • Votes against: 0 (0% of votes polled)

Overall Voting Results:

  • Total shares outstanding: 23,825,000
  • Total votes polled: 17,934 (0.07527% of total shares)
  • Total votes in favor: 17,934 (100% of votes polled)
  • Total votes against: 0 (0% of votes polled)

Resolution Outcome

The ordinary resolution for adoption of annual accounts and reports for FY ended March 31, 2024, was passed with requisite majority through remote e-voting process.

Company Status Note

The document indicates the company is under Corporate Insolvency Resolution Process (CIRP), with Namrata Amol Randeri serving as Resolution Professional (IBBI Registration No. IBBI/IPA-001/IP-P01585/2019-20/12495).

#Tags: #KoboBiotech #AGM #SEBIDisclosure #RegulatoryCompliance #CorporateGovernance #Neutral